151 related articles for article (PubMed ID: 37608043)
21. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.
Villegas MV; Pallares CJ; Escandón-Vargas K; Hernández-Gómez C; Correa A; Álvarez C; Rosso F; Matta L; Luna C; Zurita J; Mejía-Villatoro C; Rodríguez-Noriega E; Seas C; Cortesía M; Guzmán-Suárez A; Guzmán-Blanco M
PLoS One; 2016; 11(4):e0154092. PubMed ID: 27104910
[TBL] [Abstract][Full Text] [Related]
22. Enterobacteriaceae resistant to third generation cephalosporins upon hospital admission: risk factors and clinical outcomes.
Oliveira MC; Oliveira CR; Gonçalves KV; Santos MS; Tardelli AC; Nobre VA
Braz J Infect Dis; 2015; 19(3):239-45. PubMed ID: 25892313
[TBL] [Abstract][Full Text] [Related]
23. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
Lester R; Musicha P; van Ginneken N; Dramowski A; Hamer DH; Garner P; Feasey NA
J Antimicrob Chemother; 2020 Mar; 75(3):492-507. PubMed ID: 31742611
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Palacios-Baena ZR; Gutiérrez-Gutiérrez B; De Cueto M; Viale P; Venditti M; Hernández-Torres A; Oliver A; Martínez-Martínez L; Calbo E; Pintado V; Gasch O; Almirante B; Antonio Lepe J; Pitout J; Akova M; Peña-Miralles C; Schwaber MJ; Tumbarello M; Tacconelli E; Origüen J; Prim N; Bou G; Giamarellou H; Bermejo J; Hamprecht A; Pérez F; Almela M; Lowman W; Hsueh PR; Navarro-San Francisco C; Torre-Cisneros J; Carmeli Y; Bonomo RA; Paterson DL; Pascual Á; Rodríguez-Baño J;
J Antimicrob Chemother; 2017 Mar; 72(3):906-913. PubMed ID: 28062685
[TBL] [Abstract][Full Text] [Related]
26. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.
Kadri SS; Lai YL; Warner S; Strich JR; Babiker A; Ricotta EE; Demirkale CY; Dekker JP; Palmore TN; Rhee C; Klompas M; Hooper DC; Powers JH; Srinivasan A; Danner RL; Adjemian J;
Lancet Infect Dis; 2021 Feb; 21(2):241-251. PubMed ID: 32916100
[TBL] [Abstract][Full Text] [Related]
27. A Cohort Study of the Impact of Carbapenem-Resistant
Sabino S; Soares S; Ramos F; Moretti M; Zavascki AP; Rigatto MH
mSphere; 2019 Apr; 4(2):. PubMed ID: 30971443
[TBL] [Abstract][Full Text] [Related]
28. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.
Marín M; Gudiol C; Garcia-Vidal C; Ardanuy C; Carratalà J
Medicine (Baltimore); 2014 May; 93(3):143-149. PubMed ID: 24797169
[TBL] [Abstract][Full Text] [Related]
31. Third-generation cephalosporin resistant Enterobacteriaceae in neonates and young infants: impact and outcome.
Guri A; Flaks-Manov N; Ghilai A; Hoshen M; Flidel Rimon O; Ciobotaro P; Zimhony O
J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3119-3123. PubMed ID: 32878507
[TBL] [Abstract][Full Text] [Related]
32. An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
Deelen JWT; Rottier WC; Giron Ortega JA; Rodriguez-Baño J; Harbarth S; Tacconelli E; Jacobsson G; Zahar JR; van Werkhoven CH; Bonten MJM;
Clin Infect Dis; 2021 Dec; 73(11):e4475-e4483. PubMed ID: 32640024
[TBL] [Abstract][Full Text] [Related]
33. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
34. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
Liss BJ; Vehreschild JJ; Cornely OA; Hallek M; Fätkenheuer G; Wisplinghoff H; Seifert H; Vehreschild MJ
Infection; 2012 Dec; 40(6):613-9. PubMed ID: 22665143
[TBL] [Abstract][Full Text] [Related]
35. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
[TBL] [Abstract][Full Text] [Related]
36. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae.
Hammer KL; Stoessel A; Justo JA; Bookstaver PB; Kohn J; Derrick CB; Albrecht H; Al-Hasan MN
Am J Infect Control; 2016 Dec; 44(12):1611-1616. PubMed ID: 27499192
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for third-generation cephalosporin resistant Enterobacteriaceae in gestational urine cultures: A retrospective cohort study based on centralized electronic health records.
Guri A; Flaks-Manov N; Ghilai A; Hoshen M; Flidel Rimon O; Ciobotaro P; Zimhony O
PLoS One; 2020; 15(1):e0226515. PubMed ID: 31899777
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for community-onset bloodstream infection with extended-spectrum β-lactamase-producing Enterobacteriaceae: national population-based case-control study.
Isendahl J; Giske CG; Tegmark Wisell K; Ternhag A; Nauclér P
Clin Microbiol Infect; 2019 Nov; 25(11):1408-1414. PubMed ID: 30986557
[TBL] [Abstract][Full Text] [Related]
39. Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study.
Harris PNA; Pezzani MD; Gutiérrez-Gutiérrez B; Viale P; Hsueh PR; Ruiz-Garbajosa P; Venditti M; Tumbarello M; Navarro-Francisco C; Calbo E; Akova M; Giamarellou H; Oliver A; Almirante B; Gasch O; Martínez-Martínez L; Schwaber MJ; Daikos G; Pitout J; Peña C; Hernández-Torres A; Doi Y; Pérez F; Tuon FF; Tacconelli E; Carmeli Y; Bonomo RA; Pascual Á; Paterson DL; Rodríguez-Baño J;
Int J Antimicrob Agents; 2017 Nov; 50(5):664-672. PubMed ID: 28782704
[TBL] [Abstract][Full Text] [Related]
40. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to
López-Cortés LE; Rosso-Fernández C; Núñez-Núñez M; Lavín-Alconero L; Bravo-Ferrer J; Barriga Á; Delgado M; Lupión C; Retamar P; Rodríguez-Baño J;
BMJ Open; 2017 Jun; 7(6):e015439. PubMed ID: 28601833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
